Showing results (1411-1420 of 3,871) with videos related to
Sort By:
Pageof 388
Cancer Biology & Therapy|November 19, 2005
Modulation of TRAIL-induced tumor cell apoptosis in a hypoxic environmentPatrick A Mayes, Latoya Campbell, M Stacey Ricci, et al.Cancer Biology & Therapy|November 19, 2005
Cross talk between mitochondria and superoxide generating NADPH oxidase in breast and ovarian tumorsMohamed Mokhtar Desouki, Mariola Kulawiec, Sanjay Bansal, et al.Cancer Biology & Therapy|December 2, 2005
Transient exposure of mammary tumors to PD184352 and UCN-01 causes tumor cell death in vivo and prolonged suppression of tumor regrowthWilliam Hawkins, Clint Mitchell, Robert McKinstry, et al.Cancer Biology & Therapy|December 3, 2005
The role of relaxin in endometrial cancerAparna A Kamat, Shu Feng, Irina U Agoulnik, et al.Cancer Biology & Therapy|November 20, 2009
The combination of 5-fluorouracil plus p53 pathway restoration is associated with depletion of p53-deficient or mutant p53-expressing putative colon cancer stem cellsCatherine Huang, Xiang M Zhang, Raluca T Tavaluc, et al.Cancer Biology & Therapy|December 2, 2009
Downregulation of c-FLIP, XIAP and Mcl-1 protein as well as depletion of reduced glutathione contribute to the apoptosis induction of glycyrrhetinic acid derivatives in leukemia cellsDandan Song, Yuan Gao, Rui Wang, et al.Cancer Biology & Therapy|November 11, 2009
Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancerMathilde Bayet-Robert, Fabrice Kwiatkowski, Marianne Leheurteur, et al.Cancer Biology & Therapy|January 16, 2015
Wnt pathway activation and ABCB1 expression account for attenuation of proteasome inhibitor-mediated apoptosis in multidrug-resistant cancer cellsKowit Yu Chong, Chih-Jung Hsu, Tsai-Hsien Hung, et al.Cancer Biology & Therapy|December 18, 2014
Curcumin induces cell death of the main molecular myeloma subtypes, particularly the poor prognosis subgroupsPatricia Gomez-Bougie, Maxime Halliez, Sophie Maïga, et al.Cancer Biology & Therapy|January 21, 2015
Factor inhibiting HIF1α (FIH-1) functions as a tumor suppressor in human colorectal cancer by repressing HIF1α pathwayTao Chen, Zhong Ren, Le-Chi Ye, et al.Pageof 388